Acusphere leases manufacturing facility

Ultrasound contrast developer Acusphere has entered into a lease agreement for 58,000 square feet of commercial manufacturing space in Tewksbury, MA. The Watertown, MA-based vendor said it intends to develop the facility to meet its anticipated initial commercial production needs for its AI-700 ultrasound contrast agent.

AI-700 is in phase III clinical trials, and is designed for the detection of coronary heart disease. Acusphere said it currently manufactures the agent outside of Massachusetts.

By AuntMinnie.com staff writers
July 23, 2004

Related Reading

Acusphere, Nycomed ink European partnership, July 7, 2004

Ultrasound firm Acusphere launches IPO, October 15, 2003

Acusphere gets financing for development, April 21, 2003

Acusphere launches phase III trials, February 26, 2003

Acusphere raises $15 million, July 24, 2002

Copyright © 2004 AuntMinnie.com

Page 1 of 509
Next Page